DrugPatentWatch Database Preview

Dow Pharm Company Profile

Email this page to a colleague

DOW PHARM has nine approved drugs.

There is one US patent protecting DOW PHARM drugs.

There are twenty-eight patent family members on DOW PHARM drugs in twenty-two countries and nineteen supplementary protection certificates in fourteen countries.

International Patents:	28
US Patents:	1
Tradenames:	7
Ingredients:	7
NDAs:	9
Patent Litigation for Dow Pharm:	See patent lawsuits for Dow Pharm

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Dow Pharm	DOW-ISONIAZID	isoniazid	TABLET;ORAL	080330-002	Approved Prior to Jan 1, 1982		DISCN	No	No		Start Trial				Start Trial
Dow Pharm	ALTRENO	tretinoin	LOTION;TOPICAL	209353-001	Aug 23, 2018		RX	Yes	Yes		Start Trial				Start Trial
Dow Pharm	ATRALIN	tretinoin	GEL;TOPICAL	022070-001	Jul 26, 2007	AB	RX	Yes	Yes		Start Trial				Start Trial
Dow Pharm	NEO-POLYCIN	gramicidin; neomycin sulfate; polymyxin b sulfate	SOLUTION/DROPS;OPHTHALMIC	060427-001	Approved Prior to Jan 1, 1982		DISCN	No	No		Start Trial				Start Trial
Dow Pharm	NUTRACORT	hydrocortisone	LOTION;TOPICAL	080443-003	Approved Prior to Jan 1, 1982		DISCN	No	No		Start Trial				Start Trial
Dow Pharm	NUTRACORT	hydrocortisone	LOTION;TOPICAL	080443-002	Approved Prior to Jan 1, 1982		DISCN	No	No		Start Trial				Start Trial
Dow Pharm	NUTRACORT	hydrocortisone	LOTION;TOPICAL	087644-001	Aug 24, 1982		DISCN	No	No		Start Trial				Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Dow Pharm	ATRALIN	tretinoin	GEL;TOPICAL	022070-001	Jul 26, 2007	5,670,547	Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Subscribe to access the full database, or Start Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1304992	122013000081	Germany	Start Trial	PRODUCT NAME: CLINDAMYCIN (ALS CLINDAMYCIN-PHOSPHAT) UND TRETINOIN; NAT. REGISTRATION NO/DATE: 85210.00.00 20130611; FIRST REGISTRATION: IRLAND PA1332/043/001 20130322
1304992	PA2013025,C1304992	Lithuania	Start Trial	PRODUCT NAME: CLINDAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323
0809498	10C0038	France	Start Trial	PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026
0617614	SPC/GB01/014	United Kingdom	Start Trial	PRODUCT NAME: ALITRETINOIN; REGISTERED: UK EU/1/00/149/001 20001018
1304992	92401	Luxembourg	Start Trial	PRODUCT NAME: CLINDAMYCINE(EN TANT QUE PHOPSHATE DE CLINDAMYCINE)ET TRETINOINE
1304992	C300617	Netherlands	Start Trial	PRODUCT NAME: COMBINATIE VAN CLINDAMYCINE, DESGEWENST IN DE VORM VAN CLINDAMYCINEFOSFAAT EN TRETINOINE; NAT. REGISTRATION NO/DATE: RVG 109745 20130626; FIRST REGISTRATION: PA1332/043/001 20130322
0809498	SPC/GB10/012	United Kingdom	Start Trial	PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.